April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
The Influence of Anti-VEGF Agents on Intra-Retinal Lipo-Protein Exudates Assessed by Spectral Domain and Polarisation Sensitive Optical Coherence Tomography
Author Affiliations & Notes
  • M. Bolz
    Dept of Ophthalmology,
    Medical University of Vienna, Vienna, Austria
  • B. Pemp
    Department of Clinical Pharmacology,
    Medical University of Vienna, Vienna, Austria
  • J. Lammer
    Department of Ophthalmology, Medical University Vienna, Vienna, Austria
  • B. Baumann
    Ctr for Biomed Engineering & Physics,
    Medical University of Vienna, Vienna, Austria
  • B. Wetzel
    Center for biomedical engineering and physics,
    Medical University of Vienna, Vienna, Austria
  • M. Pircher
    Center for Biomed Eng & Phys,
    Medical University of Vienna, Vienna, Austria
  • C. K. Hitzenberger
    Center Biomed Eng & Phys,
    Medical University of Vienna, Vienna, Austria
  • U. Schmidt-Erfurth
    Ophthalmology,
    Medical University of Vienna, Vienna, Austria
  • Diabetic Retinopathy Research Group Vienna
    Medical University of Vienna, Vienna, Austria
  • Footnotes
    Commercial Relationships  M. Bolz, Named inventor on a patent application, P; B. Pemp, None; J. Lammer, None; B. Baumann, Named inventor on a patent application, P; B. Wetzel, None; M. Pircher, Named inventor on a patent application, P; C.K. Hitzenberger, Named inventor on a patent application, P; U. Schmidt-Erfurth, Named inventor on a patent application, P.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 5060. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Bolz, B. Pemp, J. Lammer, B. Baumann, B. Wetzel, M. Pircher, C. K. Hitzenberger, U. Schmidt-Erfurth, Diabetic Retinopathy Research Group Vienna; The Influence of Anti-VEGF Agents on Intra-Retinal Lipo-Protein Exudates Assessed by Spectral Domain and Polarisation Sensitive Optical Coherence Tomography. Invest. Ophthalmol. Vis. Sci. 2010;51(13):5060.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Hyperreflective intra-retinal foci visible in spectral domain optical coherence tomography (SD OCT) and associated with diabetic macular edema (DME) have been described previously as precursors of hard exudates. Polarisation sensitive OCT (PS OCT) allows raster scanning of the retina enabling to detect, map and measure retinal structures, such as microexudates, based on their polarization scrambling qualities. The current study was performed to analyse the changes in distribution and morphology of intraretinal microexudates in DME following monthly treatment with intravitreal anti-VEGF agents based on SD OCT and PS OCT examinations.

Methods: : Fifteen patients with persistent clinically significant macular edema due to diabetes mellitus were included in this prospective study. Patients received 3 intravitreal injections with either 1.5mg bevacizumab or 0.5mg ranibizumab in monthly intervals. The localisation of hyperreflective exudative foci and hard exudates in the central retinal area was analyzed monthly by SD OCT and PS OCTand fundus photography.

Results: : Intravitreal treatment with anti-VEGF induced a decrease in central retinal thickness from 390±32 µm to 343±33 µm until month 3. A dynamic change in the distribution pattern of microexudates was observed in SD OCT. In PS OCT, microexudates were detected and segmented automatically allowing a three-dimensional observation of their therapeutically induced dynamic changes in intra-retinal distribution. With decrease of retinal thickness single microexudates either resolved or accumulated in groups of hyperreflective foci at the border of the outer nuclear and outer plexiform layer. Once accumulated they became visible as hard exudates in fundus photography. This phenomenon of hard exudate formation could be observed in a very short time period, such as 3 days, according to the fast decrease in retinal thickness.

Conclusions: : Anti VEGF agents cause a short-term decrease in retinal thickness and induce a significant and fast change in intra-retinal lipoprotein distribution, in some cases leading to hard exudate formation in only 3 days. PS OCT is a novel and valuable technique for the automated detection of intra-retinal microexudates in vivo.

Clinical Trial: : www.clinicaltrials.gov NCT00545870

Keywords: diabetic retinopathy • imaging/image analysis: clinical • lipids 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×